United States · Funded startup

Who invested in Ocugen

4 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$151Mraised across 4 rounds since 2016, from 4 sources

$6.0MSeries A$7.5MSeries B$23MRound$115MDebt
Latest round
Debt, $115MMay 2026
Step-upi
5.1×
Investors
8
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182020202220242026
$6.0MSeries A$7.5MSeries B$23MRound$115MDebt
First round
Series A, $6.0M
Dec 2016
Biggest round
$115M
Debt · May 2026
Usual gap between rounds
6 months
the median of 3

The rounds

  1. May 2026
    Debt$115M2 returning

    Source recorded

  2. Jan 2026
  3. Jun 2017
    Series B$7.5M4 new
    • Abdi Ibrahim
    • Frank Leo
    • JSC Lancaster Group
    • John Zhang

    Reported by FinSMEsSEC filing: $7.5M sold, first sale May 2017

  4. Dec 2016
    Series A$6.0M2 new
    • Dr. Bernhard Hampl
    • EB5 Life Sciences

    Reported by FinSMEsSEC filing: $6.0M sold, first sale Nov 2016

Founders and team

From Ocugen's own website and the SEC filings it signed: 2 founders, 18 on the team.

Shankar MusunuriChairman of the Board, CEO & Co-founderNamed on its 2020 Form D
Uday B KompellaCo-founder and DirectorNamed on its 2020 Form D
  • Abhi GuptaExecutive Vice President, Commercial and Business Development
  • Paul StaidExecutive Vice President, Operations
  • Arun UpadhyayChief Scientific Officer, Head of Research & Development
  • Mohamed GeneadChief Medical Officer
  • Rita Johnson-GreeneChief Financial Officer
  • Vijay B TammaraChief Development Officer
  • Jyothy PillaiVP, Head of Regulatory & Quality
  • Kristen CraftHead of People and Culture
  • Blaise ColemanDirector
  • Jesse SimmersBoard of directors
  • John KouchGeneral Counsel
  • John ZhangDirector
  • Kirsten M. CastilloDirector
  • Satish ChandranDirector
  • Daniel B JorgensenExecutive Officeri
  • Kelly B BeckExecutive Officeri
  • Rasappa B ArumughamExecutive Officeri
  • Sanjay B SubramanianExecutive Officeri

On the board, as filediJunge ZhangKristen B CastilloManish B PottiPrabhavathi B FernandesRamesh KumarSuha B Taspolatoglu

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2016Series B2017Round2026Debt2026Janus Henderson InvestorsRTW Investments LLCAbdi IbrahimDr. Bernhard HamplEB5 Life SciencesFrank LeoJohn ZhangJSC Lancaster Group

Everyone who backed them

Janus Henderson InvestorsPrivate equity2rounds
RTW Investments LLCGrowth equity2rounds
Abdi Ibrahimno record of our own yet1round
Dr. Bernhard Hamplno record of our own yet1round
EB5 Life Sciencesno record of our own yet1round
Frank Leono record of our own yet1round
John Zhangno record of our own yet1round
JSC Lancaster Groupno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ocugen

Who invested in Ocugen?

Ocugen's investors include Janus Henderson Investors, RTW Investments LLC, Abdi Ibrahim, Dr. Bernhard Hampl and EB5 Life Sciences, and 3 more on record.

How much has Ocugen raised?

Ocugen has raised $151M across 4 rounds since 2016.

When did Ocugen last raise?

Ocugen's most recent round was a Debt of $115M in May 2026.

What was Ocugen's biggest round?

Its most recent round, $115M in May 2026, is also its largest on record.

Who backed Ocugen first?

Ocugen's first round on record, in Dec 2016, was backed by Dr. Bernhard Hampl and EB5 Life Sciences.

What stage is Ocugen at?

Ocugen's latest named round is a Debt, in May 2026.

Where is Ocugen based?

Ocugen is based in the United States.

Companies like Ocugen

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.